Logan Health Medical Center, formerly Kalispell Regional Medical Center is a 288-bed non-profit, tertiary, research and academic medical center located in Kalispell, Montana, servicing the northern Montana region. The hospital is the region's only university-level academic medical center.

During the past decade, Logan Health Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Logan Health Research" #1 sponsor was "Bayer" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Biotronik, Inc." with 1 trials sponsored, "Freenome Holdings Inc." with 1 trials sponsored and "Viela Bio (acquired by Horizon Therapeutics)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Logan Health Research" #1 collaborator was "University of Rochester" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Logan Health Research" are "Heart Failure" (2 trials), "Type 2 Diabetes" (2 trials), "Acute Myocardial Infarction" (1 trials), "Cancer" (1 trials) and "Cardiomyopathies" (1 trials). Many other conditions were trialed in "Logan Health Research" in a lesser frequency.

Most popular intervention types in "Logan Health Research" are "Drug" (5 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials), "Dulaglutide" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Logan Health Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Logan Health Research". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Logan Health Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Logan Health Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".